Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort study (2022)
Netto, Lucas C; Ibrahim, Karim Y; Picone, Camila M; Alves, Ana Paula P. S; Aniceto, Eliane V; Santiago, Mariana R; Parmejani, Patricia S. S; Bonfa, Eloisa Silva Dutra de Oliveira 
; Kallas, Esper Georges ; Silva, Vivian Helena Iida Avelino da
Source: Lancet hiv. Unidade: FM
Subjects: HIV, COVID-19, VACINAS VIRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NETTO, Lucas C et al. Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort study. Lancet hiv, v. 9, n. 5, p. E323-E331, 2022Tradução . . Disponível em: https://doi.org/10.1016/S2352-3018(22)00033-9. Acesso em: 01 maio 2026.APA
Netto, L. C., Ibrahim, K. Y., Picone, C. M., Alves, A. P. P. S., Aniceto, E. V., Santiago, M. R., et al. (2022). Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort study. Lancet hiv, 9( 5), E323-E331. doi:10.1016/S2352-3018(22)00033-9NLM
Netto LC, Ibrahim KY, Picone CM, Alves APPS, Aniceto EV, Santiago MR, Parmejani PSS, Bonfa ESD de O, Kallas EG, Silva VHIA da. Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort study [Internet]. Lancet hiv. 2022 ; 9( 5): E323-E331.[citado 2026 maio 01 ] Available from: https://doi.org/10.1016/S2352-3018(22)00033-9Vancouver
Netto LC, Ibrahim KY, Picone CM, Alves APPS, Aniceto EV, Santiago MR, Parmejani PSS, Bonfa ESD de O, Kallas EG, Silva VHIA da. Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort study [Internet]. Lancet hiv. 2022 ; 9( 5): E323-E331.[citado 2026 maio 01 ] Available from: https://doi.org/10.1016/S2352-3018(22)00033-9
